Session 2: mRNA LNP scale up for GMP Vaccine Production - Dr. Jason Coleman Published 2021-09-27 Download video MP4 360p Recommendations 25:51 Session 3: Addressing vaccine demand with rapid deployment of mRNA manufacturing - Joe Makowiecki 31:30 Science & serendipity: lipid nanoparticles that enable COVID-19 mRNA vaccines - Gairdner Lectures 23:48 CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle Platform 52:11 Recombinant Antibody Production: Current Methods and a Novel Antibody Generation Platform 23:44 Elon Musk's Bionic Eyes Are Here. 1:31:08 Perinatal Services BC - Biology of Loss: Recognizing Impaired Attachments & Fostering Resilience 10:57 Using nanopore sequencing to understand the manufacture, delivery, and action of mRNA vaccines 1:01:01 Rapid optimisation of mRNA LNP using microfluidics: Equipment, formulation and process 16:04 Large-Scale Production of Plasmid DNA & mRNA to Support Therapeutic & Vaccine Development 03:57 What are Lipid Nanoparticles (LNP)? 56:56 Richard III: The Resolution of A 500-Year-Old Cold Case 50:40 Microfluidics Webinar: Formulating Liposomes & Importance of Vesicle Size Control 28:05 Scaled Up Production of mRNA-LNPs: Strategies & Parameters 1:06:10 Constructive memory: Remembering The Past to Imagining The Future 45:23 New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy 51:54 Enabling and advancing mRNA-LNP medicines from concept to clinic 34:29 mRNA Manufacturing 54:38 How safe is it to be a living kidney donor? 1:28:40 Community Conversations: What’s new in spinal cord repair? (June 7, 2022) Similar videos 43:13 Scale Up and Manufacturing of RNA-LNPs for a COVID-19 Vaccine 1:00:07 Process & Analytical Insights for GMP Manufacturing of mRNA-Lipid Nanoparticles 21:00 Translating mRNA-Based Medicines from Concept to Clinic 22:07 Developing Scalable RNA-LNP Drug Products for Clinical Readiness 07:28 Lipid nanoparticle (LNP) production for mRNA-based vaccines 31:08 Session 1: Translation of RNA Nanomedicines from Design to Clinical - Dr. Heinrich Haas 27:22 Session 4: Aseptic Filling for mRNA LNPs - John Harmer 28:16 Session 5: RNA Vaccine Development to Phase I - Dr. John Lewis 09:49 S2: Characterization & Analysis of saRNA in Lipid Nanoparticles for Drug Delivery - Dr. Adam Crowe 58:36 Streamlined mRNA Synthesis for Increased Protein Expression-TIDES Digital Week 1:11:52 Vaccine Manufacturing Workflow 01:33 WHO mRNA vaccine hub: a game changer for building local manufacturing capacities More results